    Peter Edwardson | Oxford Immunotec Ltd | ZoomInfo.com

Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Peter Edwardson Ph.D.: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 11:51 AM ET
Healthcare Equipment and Supplies

Company Overview of Oxford Immunotec Global PLC



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Peter   Edwardson Ph.D.Chief Operations Officer, Oxford Immunotec Global PLCAgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.55--As of Fiscal Year 2015
Background

		Dr. Peter Edwardson, PhD., has been the Chief Operations Officer of Oxford Immunotec Global PLC and Oxford Immunotec Limited since October 2013, overseeing operations worldwide, including all manufacturing, research and development activities, quality assurance and regulatory affairs and laboratory operations. Dr. Edwardson served as General Manager of operations in the United Kingdom, with primary responsibility for all manufacturing and research and development. Dr. ... Edwardson served as the Chief Scientific Officer of Oxford Immunotec Ltd. Dr. Edwardson has over 20 years experience in the medical device industry in both small start-up companies and large corporations. Dr. Edwardson served as a Project Director of Pathogen Removal and Diagnostic Technologies at Prometic Life Sciences Inc. and served as its Vice President of Medical Technologies since October 2007. He oversees the commercial phase of PRDT's P-Capt(R) filter in conjunction with Macopharma. Dr. Edwardson also direct the development of new medical applications for ProMetic's proven platform technologies, including those for BSafE diagnostics applications. He served as a Vice President of Medical Technologies, Prometic Biosciences Ltd. since October 2007, where he led a joint venture with the American Red Cross to develop products to remove pathogens from blood. Prior to this, he served as Technical Director at Tayside Flow Technologies and Tissuemed Ltd., start-up companies focused on development and commercialization of implantable devices. He is author of numerous scientific publications and international patents and has a PhD from Cambridge University. Dr. Edwardson earned his Bachelors degree in Biochemistry and Physiology from Leeds University.Read Full Background




Corporate Headquarters
115D Innovation DriveAbingdon, Oxfordshire OX14 4RZUnited KingdomPhone: 44 1235 442780Fax: 44 1235 442781
Board Members Memberships
				There is no Board Members Memberships data available.
				Education
PhD University of CambridgeBachelor's Degree University of Leeds
Other Affiliations
ProMetic Life Sciences Inc.University of CambridgeUniversity of LeedsOxford Immunotec Limited


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationDavid P. King J.D.Chairman, Chief Executive Officer and PresidentLaboratory Corporation of America Holdings$1.1MPeer Michael Schatz CEO, MD & Member of Management BoardQIAGEN N.V.$1.3MStephen H. Rusckowski Chairman, Chief Executive Officer and PresidentQuest Diagnostics Incorporated$1.1MCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Oxford Immunotec Global PLC, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























Peter  Edwardson - Rancho Cucamonga, CA | Intelius



























Sign In



We found Peter  Edwardson in Rancho Cucamonga, CA


Peter  Edwardson

                                                                        Intelius found that Peter  Edwardson  from Rancho Cucamonga, CA.  We have connected them to
                2 addresses,
                2 phones,
                and 0 relatives or associates.
         





Also Known As

Pete  Edward


Get Report Now

Peter Has Lived In

Rancho Cucamonga, CA
Ontario, CA







Peter  Edwardson



Professional Status
Government Affairs Manager at Air Showers & Pass-thrus Unltd



Get Report Now










Want to know more about Peter? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Peter, or use our people search engine to find others.
Get Background Check on Peter  Edwardson
Get a Criminal Check on Peter  Edwardson
Get a Public Record Report on Peter  Edwardson
Get a People Search Report on Peter  Edwardson


Peter  Edwardson's Contact Information
Known Cities Lived In
Find out where Peter  Edwardson has lived as well as Peter  Edwardson's phone numbers and email addresses.




Peter  Edwardson Has Lived in 1 States
California Address for Peter  Edwardson


 P* B** 4** 

Rancho Cucamonga, CA


Has Lived In

Rancho Cucamonga, CA
Ontario, CA


Get Full Address Report










Phone Numbers Associated with Peter  Edwardson

(909) ***-**** - Rancho Cucamonga, CA 
(909) ***-**** - Ontario, CA 


Get Full Phone Report



Email Addresses Associated with Peter  Edwardson

p*****d@***.org
p*************n@***.com
p********n@***.org


Get Email Report




Peter  Edwardson's Professional Information
Information regarding Peter  Edwardson's professional history.  Find out previous places Peter  Edwardson has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Peter  Edwardson Has Worked at 3 Places
Company: Air Showers & Pass-thrus Unltd
               Title: Government Affairs Manager
Company: Calvary Baptist Church
               Title: Religious Leader
Peter  Edwardson's Experience
Title: Government Affairs Manager
               Company: Air Showers & Pass-thrus Unltd
Job Details
               Company Size: Less than $1 mil - Employee Range: Less than 25
Title: Religious Leader
               Company: Calvary Baptist Church
Job Details
               Company Size: $1 mil to less than $5 mil - Employee Range: 25 to less than 100. Company Size: Less than $1 mil - Employee Range: Less than 25.
Additional Professional Information on Peter  Edwardson

 See Peter  Edwardson's LinkedIn Profile



Peter  Edwardson's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Peter  Edwardson


Peter  Edwardson's known Social Networks And Potential Email Matches

Find all of Peter  Edwardson's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Peter Edwardson
Username Matches

                  PeterEdwardson
                  EdwardsonPeter
                  Peter.Edwardson
                  Edwardson.Peter
                  Peter_Edwardson
                  Edwardson_Peter
                  Peter-Edwardson
                  Edwardson-Peter
                  PEdwardson
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
P Edwardson







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














Management - Oxford Immunotec International














































Home
Products & Services

The T-SPOT.TB

Test Overview
How the Test Works
The Science Behind the Test
Clinical Data


T-SPOT®.CMV
T-SPOT®.PRT
T-Cell Xtend®
Testing Services


Science

Technology
Product Pipeline
Clinical Studies
Investigator Initiated Studies
Medical Education

Applying for a Grant




Company

About Us
Our Vision
Our Values
Management Team
Board of Directors


News & Events

News
Industry Events
Awards & Recognition


Investors 

Overview
Press Releases
Events & Presentations
Corporate Governance

Management
Board of Directors
Committee Composition
Annual Reports and Proxies
Annual Meeting


Financials & Filings

Quarterly Results
Key Ratios


Stock Information

Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile


Investor FAQs
Contact Us


Join Our Team




Home
Products & Services

T-SPOT®.TB
T-SPOT®.CMV
T-SPOT®.PRT
T-Cell Xtend®
Testing Services


Science

Technology
Product Pipeline
Clinical Studies
Investigator Initiated Studies
Medical Education

Applying for a Grant




Company

About Us
Our Vision
Our Values
Management Team
Board of Directors


Product Video
News & Events

News
Industry Events
Awards & Recognition


Investors 

Overview
Press Releases
Events & Presentations
Corporate Governance

Management
Board of Directors
Committee Composition
Annual Reports and Proxies
Annual Meeting


Financials & Filings

Quarterly Results
Key Ratios


Stock Information

Historic Stock Lookup
Investment Calculator
Analyst Coverage
Ownership Profile


Investor FAQs
Contact Us


Join Our Team


 



Harnessing the power of T cell measurement



 




Contact Us

Contact Us
Office Locations
Worldwide Distributors












Contact Us

Contact Us
Office Locations
Worldwide Distributors











 



















Shareholder Tools

Briefcase
Printed Materials
Email Alerts
 Download
Snapshot
RSS
Print
Search
 Share






Facebook
Google
LinkedIn
Twitter
Email
RSS











Management
Show all 



Peter Wrighton-Smith Ph.D.
Chief Executive Officer




	Dr. Wrighton-Smith is our Chief Executive Officer and a Director. He has held both positions since founding Oxford Immunotec in 2002. Before founding Oxford Immunotec, Dr. Wrighton-Smith held senior positions with PowderJect Pharmaceuticals PLC, including senior projects director, a business development role, and managing director of PowderJect Diagnostics Ltd., a subsidiary of PowderJect engaged in the development of cellular immune based diagnostics. During his tenure with PowderJect, the company became a global vaccines business with more than 1,000 employees. Dr. Wrighton-Smith has a Masters in Engineering, Economics & Management, and a Doctorate in Medical Engineering, both from Oxford University.





Richard Altieri
Chief Financial Officer




	Mr. Altieri is our Chief Financial Officer, a position he has held since joining our company in 2012. Before joining Oxford Immunotec, from 2007 through 2011, Mr. Altieri was vice president and chief financial officer of Salient Surgical Technologies, Inc., a medical technology company that developed and marketed surgical advanced energy products. From 2004 to 2007, Mr. Altieri was senior vice president of finance and chief financial officer of Straumann USA, a global leader in the field of implant dentistry and dental tissue regeneration. Earlier in his career, beginning in 1992, Mr. Altieri was vice president and chief financial officer of Mitek Surgical Products, Inc., which was acquired by Johnson & Johnson in 1995. Following the acquisition, Mr. Altieri continued to oversee the financial operations of DePuy Mitek as vice president – finance through 2004. Mr. Altieri earned his Bachelors degree in Accounting from Northeastern University and his Masters in Business Administration from Babson College.





Jeff Schroeder
Chief Commercial Officer




	Mr. Schroeder has been our Chief Commercial Officer since 2013, overseeing worldwide sales and marketing operations. Prior to becoming our Chief Commercial Officer, Mr. Schroeder served as our President, North America from 2007 to 2013, overseeing sales and marketing operations in the United States. Before joining Oxford Immunotec, from 2002 to 2007, he served as vice president of sales, breast health and vice president of marketing at Cytyc Corporation, which manufactured and sold tests used in the diagnosis of cervical cancer and other women's health-related illnesses and merged with Hologic Corporation in 2007. Before working at Cytyc, from 2000 to 2002, Mr. Schroeder was vice president, sales and marketing for CytoLogix Corporation, a cellular diagnostics company. Earlier in his career, from 1984 to 2000, Mr. Schroeder held various sales positions with increasing levels of responsibility for the diagnostics division of Abbott Laboratories, ultimately becoming director of worldwide marketing for the division. Mr. Schroeder earned his Bachelors degree from Southeast Missouri State University.





Peter Edwardson Ph.D.
Chief Operations Officer




	Dr. Edwardson has been our Chief Operations Officer since 2013, overseeing our operations worldwide, including all manufacturing, research and development activities, quality assurance and regulatory affairs and laboratory operations. Prior to becoming our Chief Operations Officer, Dr. Edwardson served as General Manager of our operations in the United Kingdom, with primary responsibility for all manufacturing and research and development activities. Dr. Edwardson joined Oxford Immunotec in 2008 and has over 20 years of experience in the medical device industry in both small start-up companies and large corporations. Immediately before joining Oxford Immunotec, from 2003 to 2008, Dr. Edwardson was vice president of medical technologies for Prometic Biosciences Ltd., a subsidiary of Prometic Life Sciences Inc., which designed, developed, manufactured and commercialized affinity adsorbents sold to biopharmaceutical companies for use in their drug manufacturing processes. From 1999 to 2003, he served as technical director at Tayside Flow Technologies and Tissuemed Ltd, two start-up companies focused on development and commercialization of implantable devices. Dr. Edwardson earned his Bachelors degree in Biochemistry and Physiology from Leeds University and his Doctorate from Cambridge University.





Elizabeth M. Keiley
Senior Vice President and General Counsel




	Ms. Keiley is our Senior Vice President, General Counsel, having been promoted in March 2017. From January 2015 to March 2017, she held the position of Vice President, General Counsel. In this role, Ms. Keiley has had responsibility for all of our legal affairs. She joined us in September 2012 and served as Associate General Counsel until her promotion in January 2015 to Vice President, General Counsel. Before joining us, from July 2008 to March 2012, Ms. Keiley was Assistant General Counsel, Americas of Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., the world’s largest pure-play orthopedic device manufacturer. Before working at Zimmer, Ms. Keiley was a trial lawyer and partner with Wildman, Harrold, Allen & Dixon in Chicago, Illinois where she represented clients in a wide variety of commercial disputes and transactions. Ms. Keiley earned her bachelor’s degree in Psychology/Philosophy from Boston College and her juris doctor from Loyola University School of Law.





Stephen M. Gansler
Senior Vice President and Global Head of Human Resources



Mr. Gansler joined Oxford Immunotec as our Senior Vice President and Global Head of Human Resources, overseeing our Human Resources functions worldwide.  Before joining us, Mr. Gansler was Senior Vice President, Human Resources, for Millennium Pharmaceuticals, now Millennium: The Takeda Oncology Company, where he played a key leadership role, implementing employee engagement and integrated talent management programs which contributed to Millennium's consistent ranking during his tenure as one of the best places to work in the United States.  Prior to Millennium, Mr. Gansler spent more than twenty years with Johnson & Johnson, holding a variety of roles of increasing responsibility, including Worldwide Vice President, Human Resources.   During his tenure with J & J, he led the human resources function for four separate business units and managed several post-acquisition integrations.   He also designed innovative compensation programs that aligned rewards with performance and implemented fundamental changes to leadership development and succession planning for J &J's 80,000 employees.  Mr. Gansler received his Bachelor Industrial Administration from the General Motors Institute and a Master of Business Administration-Finance and Juris Doctor from Seton Hall University.









Briefcase
Printed Materials
Email Alerts
 Download
Snapshot
RSS
Print
Search
 Share






Facebook
Google
LinkedIn
Twitter
Email
RSS

















 

Peter Edwardson, Oxford Immunotec Global PLC: Profile & Biography - Bloomberg


































































  


























Feedback





Peter Edwardson

Chief Operations Officer,
Oxford Immunotec Global PLC






Career History




Chief Operations Officer
Oxford Immunotec Ltd, 2013-PRESENT


Chief Operations Officer
Oxford Immunotec Global PLC, 10/2013-PRESENT


General Manager:Operations
Oxford Immunotec Ltd, 2008-2013


VP:Medical Technologies
Prometic Biosciences Ltd, 2003-2008


Technical Director
Tayside Flow Technologies, 1999-2003


Technical Director
Tissuemed Ltd, FORMER


Show More









Website:
www.oxfordimmunotec.com






Corporate Information
Address:

94C Innovation Drive
Milton Park
Abingdon, OX14 4RZ
United Kingdom


Phone:
44-1235-442-780


Fax:
44-1235-442-781


Web url:
www.oxfordimmunotec.com











From The Web












Personal Information



Education



University of Cambridge
PhD


University of Leeds
Bachelor's Degree








Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data


































Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft










Oxford Immunotec Global PLC (OXFD.OQ)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Oxford Immunotec Global PLC (OXFD.OQ)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareAdvanced Medical Equipment & Technology












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				OXFD.OQ on NASDAQ Stock Exchange Global Market


				16.46USD
11:28am EDT





				    Change	(% chg)


		    
						    $-0.09


					            (-0.54%)
					        






Prev Close

$16.55


Open

$16.54




Day's High

$16.76


Day's Low

$16.35




Volume

4,309


Avg. Vol

27,223




52-wk High

$17.35


52-wk Low

$7.93











					Summary





Name
Age
Since
Current Position




							Richard Sandberg

73
2008

                                Independent Chairman of the Board




							Peter Wrighton-Smith

41
2002

                                Chief Executive Officer, Director




							Richard Altieri

55
2012

                                Chief Financial Officer




							Peter Edwardson

52
2013

                                Chief Operating Officer




							Stephen Gansler

60
2015

                                Senior Vice President and Global Head of Human Resources




							Elizabeth Keiley

49
2015

                                Vice President, General Counsel




							Jeff Schroeder

53
2013

                                Chief Commercial Officer




							Richard Wenstrup

64
2017

                                Chief Medical Officer




							.. ..


2015

                                Director




							Ronald Andrews

53
2015

                                Director




							Patrick Balthrop

58
2016

                                Director




							Patricia Randall

64
2014

                                Director




							Nigel Pitchford

45
2012

                                Independent Director




							Herman Rosenman

67
2013

                                Independent Director




							Stephen Spotts

60
2010

                                Independent Director




							James Tobin

72
2014

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Richard Sandberg


					
							Mr. Richard A. Sandberg is the Independent Chairman of the Board of the company. He has played a principal role in starting and building a number of medical diagnostic companies including that of founder, chairman, chief executive officer, and chief financial officer of DIANON Systems Inc., a publicly traded oncology diagnostics company that was a pioneer in marketing new diagnostic technologies as a service rather than a product offering. He also served as chairman and chief financial officer of Lifecodes Corporation, a pioneer in DNA testing technology; chief financial officer and director of Matritech, Inc., a publicly traded biotechnology company specializing in proteomic diagnostic products for the early detection of a variety of cancers; and as chief financial officer of Critical Diagnostics, Inc., a company specializing in developing new diagnostic tests for cardiology. He has also served as a director of North American Scientific Inc., a publicly held developer and marketer of radiation therapy products and systems for treating breast and prostate cancer, from 2005 to 2009; as a director of Ethan Allen Interiors Inc., an international manufacturer and retailer of fine home furnishings, from 2003 to 2009; and serves as chairman of two privately held diagnostic companies. Mr. Sandberg earned his Bachelors degree in Business from Northwestern University and a Masters in Business Administration from Harvard University.




							Peter Wrighton-Smith


					
							Dr. Peter Wrighton-Smith is the Chief Executive Officer and Director of Oxford Immunotec Global PLC. He has held both positions since founding Oxford Immunotec in 2002. Before founding Oxford Immunotec, Dr. Wrighton-Smith held senior positions with PowderJect Pharmaceuticals PLC, now part of Chiron Corporation, including senior projects director, a business development role, and managing director of PowderJect Diagnostics Ltd., a subsidiary of PowderJect engaged in the development of cellular immune based diagnostics. During his tenure with PowderJect, the company became a global vaccines business with more than 1,000 employees. Dr. Wrighton-Smith has a Masters in Engineering, Economics & Management, and a Doctorate in Medical Engineering, both from Oxford University.




							Richard Altieri


					
							Mr. Richard M. Altieri is the Chief Financial Officer of Oxford Immunotec Global PLC. Mr. Altieri is our Chief Financial Officer, a position he has held since joining us in January 2012. Before joining the Company, from July 2007 through December 2011, Mr. Altieri was vice president and chief financial officer of Salient Surgical Technologies, Inc., a medical technology company that developed and marketed surgical advanced energy products. From 2004 to 2007, Mr. Altieri was senior vice president of finance and chief financial officer of Straumann USA, a global leader in the field of implant dentistry and dental tissue regeneration. Earlier in his career, beginning in 1992, Mr. Altieri was vice president and chief financial officer of Mitek Surgical Products, Inc., which was acquired by Johnson & Johnson in 1995. Following the acquisition, Mr. Altieri continued to oversee the financial operations of DePuy Mitek as vice president – finance through 2004. Mr. Altieri earned his Bachelors degree in Accounting from Northeastern University and his Masters in Business Administration from Babson College.




							Peter Edwardson


					
							Dr. Peter Edwardson, Ph.D. is the Chief Operating Officer of the company. Dr. Edwardson has been our Chief Operations Officer since October 2013, overseeing our operations worldwide, including all manufacturing, research and development activities, quality assurance and regulatory affairs and laboratory operations. Prior to becoming our Chief Operations Officer, Dr. Edwardson served as General Manager of our operations in the United Kingdom, with primary responsibility for all manufacturing and research and development activities. Dr. Edwardson joined Oxford Immunotec in 2008 and has over 20 years of experience in the medical device industry in both small start-up companies and large corporations. Immediately before joining Oxford Immunotec, from 2003 to 2008, Dr. Edwardson was vice president of medical technologies for Prometic Biosciences Ltd., a subsidiary of Prometic Life Sciences Inc., which designed, developed, manufactured and commercialized affinity adsorbents sold to biopharmaceutical companies for use in their drug manufacturing processes. From 1999 to 2003, he served as technical director at Tayside Flow Technologies and Tissuemed Ltd, two start-up companies focused on development and commercialization of implantable devices. Dr. Edwardson earned his Bachelors degree in Biochemistry and Physiology from Leeds University and his Doctorate from Cambridge University.




							Stephen Gansler


					
							Mr. Stephen M. Gansler is Senior Vice President and Global Head of Human Resources of Oxford Immunotec Global PLC. Mr. Gansler brings to Oxford Immunotec more than 25 years of experience in managing and leading the human resource function at life sciences companies. Most recently, Mr. Gansler was Senior Vice President, Human Resources, for Millennium Pharmaceuticals, where he played a key leadership role in the company's growth. During his tenure with Millennium, it was consistently ranked as one of the best places to work in the United States. Before joining Millennium, Mr. Gansler spent more than 20 years with Johnson & Johnson, holding a variety of roles of increasing responsibility, including the head of human resources for four separate business units, and successfully leading several post-acquisition integrations. Mr. Gansler received his Bachelor Industrial Administration from the General Motors Institute and a Master of Business Administration-Finance and Juris Doctor from Seton Hall University.




							Elizabeth Keiley


					
							Ms. Elizabeth M. Keiley is the Vice President, General Counsel, of the company a position she has held since January 1, 2015. Ms. Keiley joined the Company in September 2012 as Associate General Counsel. She was promoted to Vice President, General Counsel effective January 1, 2015 and in this role has responsibility for all of our legal affairs. Before joining us, from July 2008 to March 2012, Ms. Keiley was Assistant General Counsel, Americas of Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., the world’s largest orthopedic device manufacturer. Before working at Zimmer, Ms. Keiley was a trial lawyer and partner with Wildman, Harrold, Allen & Dixon in Chicago, Illinois where she represented clients in a wide variety of commercial disputes and transactions. Ms. Keiley earned her Bachelors degree in Psychology/Philosophy from Boston College and her Juris Doctor from Loyola University School of Law.




							Jeff Schroeder


					
							Mr. Jeff R. Schroeder is the Chief Commercial Officer of the company. Mr. Schroeder has been Chief Commercial Officer since October 2013, overseeing worldwide sales and marketing operations. Prior to becoming Chief Commercial Officer, Mr. Schroeder served as our President, North America from February 2007 to October 2013, overseeing sales and marketing operations in the United States. Before joining Oxford Immunotec, from 2002 to 2007, he served as vice president of sales, breast health and vice president of marketing at Cytyc Corporation, which manufactured and sold tests used in the diagnosis of cervical cancer and other women’s health-related illnesses and merged with Hologic Corporation in 2007. Before working at Cytyc, from 2000 to 2002, Mr. Schroeder was vice president, sales and marketing for CytoLogix Corporation, a cellular diagnostics company. Earlier in his career, from 1984 to 2000, Mr. Schroeder held various sales positions with increasing levels of responsibility for the diagnostics division of Abbott Laboratories, ultimately becoming director of worldwide marketing for the division. Mr. Schroeder earned his Bachelors degree from Southeast Missouri State University.




							Richard Wenstrup


					
							Mr. Richard Wenstrup, M.D., serves as Chief Medical Officer of the Company. Dr. Wenstrup brings to Oxford Immunotec more than 20 years of clinical leadership experience, including over a decade within the diagnostics industry. Most recently, Dr. Wenstrup served as Executive Vice President, Chief Medical Officer, for Myriad Genetics, Inc., where he played a key leadership role and made substantial contributions across the company that helped drive and support a multi-fold increase in revenue over a decade. In addition to building and leading Myriad's clinical and medical affairs teams, Dr. Wenstrup was actively involved in the company's product development, M&A, and in-licensing activities. He also previously served as Chief Medical Officer for Myriad Genetic Laboratories, Inc. Prior to joining Myriad Genetics, Dr. Wenstrup served as a tenured Professor of Pediatrics (Human Genetics) at Cincinnati Children's Hospital Medical Center and as a tenured Professor of Biomedical Engineering at the University of Cincinnati. During his time in academia, Dr. Wenstrup was principal investigator on multiple research grants from the National Institutes of Health (NIH) and the FDA Orphan Products Grant Program. He also served as a standing member of NIH review committees and on the scientific advisory boards of several disease-related foundations. Dr. Wenstrup was the founding director of the Molecular Diagnostics Laboratory at Cincinnati Children's Hospital and co-founder of Assurex Health, Inc., now a subsidiary of Myriad Genetics, Inc.




							.. ..


					
							Mr. Andrew Scott Walton is Director of the Company. Mr. Walton is currently the Chief Executive Officer of Ameritox, a company that offers laboratory testing and practice management tools to help clinicians coordinate and optimize the care of chronic pain and behavioral health patients. Prior to Ameritox, he held senior leadership positions within LabCorp, most recently as Executive Vice President of the esoteric testing business and a member of LabCorp’s five-person Executive Committee. Before leading the esoteric businesses at LabCorp, Mr. Walton had numerous roles with the company including heading up strategic planning and mergers & acquisitions, and serving as the company’s Chief Information Officer. Mr. Walton earned his Bachelor’s degree from Yale University and a Master of Business Administration degree from the Harvard Business School.




							Ronald Andrews


					
							Mr. Ronald A. Andrews, Jr. is Director of the Company. Mr. Andrews most recently served as President of the Genetic Sciences Division of Thermo Fisher Scientific, a position he assumed upon Thermo Fisher’s acquisition of Life Technologies Corporation, where he had been the President of the Medical Sciences Venture. Following the acquisition, Mr. Andrews led the integration of Life Technologies’ next generation sequencing technology into the Thermo Fisher product line. Prior to that, Mr. Andrews served as Chief Executive Officer of GE Molecular Diagnostics, a position he assumed upon GE’s acquisition of Clarient Inc., a NASDAQ-listed oncology-focused clinical laboratory service company, at which Mr. Andrews had been serving as Chief Executive Officer. He is currently a member of the Board of Governors of CancerLinQ LLC, a wholly-owned non-profit subsidiary of the American Society of Clinical Oncology and a member of the Board of the Mission Hospital Foundation. Mr. Andrews earned his Bachelor’s degree from Wofford College.




							Patrick Balthrop


					
							Mr. Patrick J. Balthrop, Sr. is Director of Oxford Immunotec Global PLC. Most recently, Mr. Balthrop served as President and CEO of Luminex Corporation (Nasdaq: LMNX) from 2004 to 2014, during which time the company’s revenues grew eightfold. During his tenure at Luminex, Mr. Balthrop implemented innovative R&D programs which led to the development and subsequent successful commercialization of a long list of new products, oversaw multiple significant acquisitions and drove a 66% gross margin improvement. Before joining Luminex, Mr. Balthrop served as President of Fisher Healthcare, which is now a division of Thermo Fisher Scientific, Inc., where he was responsible for the successful turnaround of a $1 billion integrated healthcare products manufacturing and distribution business. Prior to that, Mr. Balthrop held multiple positions at Abbott Laboratories, where he played an integral part in the development and global commercialization of a number of high profile diagnostic products. Mr. Balthrop holds an M.B.A. from the Kellogg Graduate School of Management, Northwestern University and a B.S. from Spring Hill College. He currently serves as a Director at Personalis and NextGxDx, as an advisor to Water Street Healthcare Partners and Warburg Pincus, and as the Founding Principal at Apalachee Ventures.




							Patricia Randall


					
							Ms. Patricia Randall is the Director of the company. Ms. Randall joined Oxford Immunotec in 2008 and has responsibility for legal affairs. Ms. Randall has more than 35 years of experience as a lawyer and advisor to both public and private companies in a wide range of industries. Before joining Oxford Immunotec, from 2003 to 2008, Ms. Randall served as vice president, general counsel and secretary of Matritech, Inc., a biotechnology company specializing in proteomic diagnostic products for the early detection of a variety of cancers. Before joining Matritech, she served as vice president and general counsel of Hadco Corporation, a global manufacturer of printed circuit boards, and as vice president and general counsel of Robotic Vision Systems, Inc., a leading supplier of machine vision technologies. In November 2004, more than twenty months after Ms. Randall’s departure from Robotic Vision Systems, Inc., that company filed a petition under the federal bankruptcy laws. Ms. Randall earned her Bachelors degree from American University in Philosophy and her Juris Doctor from Northeastern University School of Law.




							Nigel Pitchford


					
							Dr. Nigel A. Pitchford is the Independent Director of Oxford Immunotec Global PLC. Dr. Pitchford is currently the Chief Investment Officer and a director of Imperial Innovations Group plc (AIM), or Innovations, and leads Innovations’ investment activities. From 2011 until October 2013, Dr. Pitchford was the Managing Director of Healthcare at Innovations, where he led the firm’s activities in the healthcare sector. From 2009 to 2011, he was a partner at DFJ Esprit and in that capacity served as a member of our Board of Directors from 2010 to 2011. Before joining DFJ Esprit, Dr. Pitchford spent twelve years, from 1997 to 2009, at 3i Group plc, an international investment company focused on mid-market private equity, infrastructure and debt management, where he led the venture team’s healthcare activities across Europe and the United States. Dr. Pitchford earned his Bachelors degree in Chemistry at Oxford University and his Doctorate in Chemistry at the University of Durham. He also has a Masters degree in Business Administration from the Warwick Business School of University of Warwick.




							Herman Rosenman


					
							Mr. Herman Rosenman CPA is the Independent Director of the Company. Mr. Rosenman served as senior vice president, finance and chief financial officer of Gen-Probe Incorporated, a publicly traded molecular diagnostics company, from 2001 through the sale of that company to Hologic, Inc. in August 2012. From 1997 to 2000, Mr. Rosenman served as president and chief executive officer of Ultra Acquisition Corp., a manufacturer and parts retailer. From 1994 to 1997, he served as president and chief executive officer of RadNet Management, Inc., a healthcare provider. He has also served as chief financial officer of Rexene Corp. and was an audit partner at Coopers & Lybrand (now PricewaterhouseCoopers LLP). Mr. Rosenman currently serves as a member of the board of directors and audit committee chairman of Vivus, Inc., a publicly traded biopharmaceutical company, Medistem, Inc., a stem cell therapy company, and BioFire Diagnostics, Inc., a molecular diagnostics company, as well as an advisory board member of Scripps Clinics/Green Hospital, a large healthcare provider in San Diego, CA. Previously, he has served on numerous public and private company boards of directors, frequently as a member of the company’s audit committee, including ARYx Therapeutics, Infinity Pharmaceuticals, Inc., Emphasys Medical, Inc. and Discovery Partners International, Inc. Mr. Rosenman is a certified public accountant who received a B.B.A. in finance and accounting from Pace University and a Masters in Business Administration in finance from the Wharton School of the University of Pennsylvania.




							Stephen Spotts


					
							Mr. Stephen L. Spotts is the Independent Director of Oxford Immunotec Global PLC. Mr. Spotts is a Director, a position he has held since November 2010. Mr. Spotts is chief executive officer, president, director and founder of ProTom International, Inc., a medical technology company focused on proton therapy for cancer patients founded in 2007. Before founding ProTom, from 2000 to 2006, Mr. Spotts was president, chief executive officer, and a member of the board of directors of Pathology Partners, Inc. (now known as Miraca Life Sciences, Inc.). From 2005 through mid-2008, he served on the board of directors of Genoptix, Inc., a California-based, publicly traded specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists (Genoptix, Inc. was acquired by Novartis AG in 2011). Mr. Spotts earned his Bachelors degree in Business Administration from the University of Mississippi.




							James Tobin


					
							Mr. James R. Tobin is the Independent Director of the Company., since December 1, 2014, Mr. Tobin served as President and Chief Executive Officer of Boston Scientific from March 1999 to July 2009 during which time the company’s revenues grew from more than $2 billion to over $8 billion. During his tenure, Boston Scientific achieved a number of significant milestones, including the successful commercial launch of numerous products, significant acquisitions and strategic alliances (including the transformative acquisition of Guidant Corporation), and the growth of Boston Scientific’s international business to more than 40% of the company’s annual revenues. Before joining Boston Scientific, Mr. Tobin served as President and CEO of Biogen Idec Inc., where he was instrumental in making it one of the world’s most successful biotechnology companies. Prior to that, Mr. Tobin was an executive with Baxter International. He became President and Chief Operating Officer of Baxter in 1992 and was responsible for all operations of the $9 billion company. Mr. Tobin holds an M.B.A. from Harvard Business School and an A.B. from Harvard College.











					Basic Compensation





Name
Fiscal Year Total




							Richard Sandberg

--




							Peter Wrighton-Smith

1,421,440




							Richard Altieri

405,775




							Peter Edwardson

795,144




							Stephen Gansler

--




							Elizabeth Keiley

--




							Jeff Schroeder

825,377




							Richard Wenstrup

--




							.. ..

--




							Ronald Andrews

--




							Patrick Balthrop

--




							Patricia Randall

--




							Nigel Pitchford

--




							Herman Rosenman

--




							Stephen Spotts

--




							James Tobin

--



As Of 
30 Dec 2014





					Options Compensation





Name
Options
Value




							Richard Sandberg

0
0




							Peter Wrighton-Smith

0
0




							Richard Altieri

0
0




							Peter Edwardson

0
0




							Stephen Gansler

0
0




							Elizabeth Keiley

0
0




							Jeff Schroeder

0
0




							Richard Wenstrup

0
0




							.. ..

0
0




							Ronald Andrews

0
0




							Patrick Balthrop

0
0




							Patricia Randall

0
0




							Nigel Pitchford

0
0




							Herman Rosenman

0
0




							Stephen Spotts

0
0




							James Tobin

0
0









					Insider Trading












Name
Shares Traded
Price


Wrighton-Smith (Peter James Ph.D.)
27,168
$15.94


Wrighton-Smith (Peter James Ph.D.)
27,168
$0.81


Wrighton-Smith (Peter James Ph.D.)
16,394
$0.81


Wrighton-Smith (Peter James Ph.D.)
16,438
$0.81


Wrighton-Smith (Peter James Ph.D.)
16,394
$16.58


Wrighton-Smith (Peter James Ph.D.)
16,438
$16.58


Wrighton-Smith (Peter James Ph.D.)
30,000
$16.06


Wrighton-Smith (Peter James Ph.D.)
30,000
$0.81


Keiley (Elizabeth M)
4,085
$15.01


Keiley (Elizabeth M)
1,136
$14.63


Sandberg (Richard A)
2,174
$0.00


Edwardson (Peter)
10,000
$14.66


Sandberg (Richard A)
3,000
$0.81


Sandberg (Richard A)
3,000
$14.40


Schroeder (Jeff R)
22,397
$14.01


Schroeder (Jeff R)
17,603
$14.30


Edwardson (Peter)
21,460
$0.26


Edwardson (Peter)
42,913
$0.09


Edwardson (Peter)
22,371
$0.09


Schroeder (Jeff R)
42,804
$0.09


Schroeder (Jeff R)
22,371
$0.09


Wrighton-Smith (Peter James Ph.D.)
30,000
$0.81


Sandberg (Richard A)
3,000
$15.47


Wrighton-Smith (Peter James Ph.D.)
30,000
$15.43


Keiley (Elizabeth M)
3,000
$0.81




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareAdvanced Medical Equipment & Technology






















Peter Edwardson                                                                                                          - Riverside                                         , CA         - Company Information









 



























Products
Resources
My Account












Talk to a D&B Advisor 
1-800-280-0780 




Business Directory



CA



Riverside



Lumber, Plywood, and Millwork



Wholesale - Doors And Windows



                            Peter Edwardson
                                    



 





















P 


Peter Edwardson                                                                                                         
CLAIM THIS BUSINESS



4937 NEWCASTLE ST RIVERSIDE, CA 92509
Get Directions



(951) 360-1148
 





Business Info



 Founded 1993
 Incorporated 
 Annual Revenue $253,990.00
 Employee Count 2
 Industries Wholesale - Doors And Windows
 Contacts Peter Edwardson                                                                                                         







Contact Business







Your Email Address

Subject:


Message


Send Message





Company Summary


Since 1993 the company has been providing Wholesale - Doors And Windows. 









VERIFIED Status:
UNVERIFIED



Address:
UNVERIFIED





LAST VERIFIED:

                                    --
                                



Phone:

                                    UNVERIFIED
                                





Payment Method:
UNVERIFIED


view full report





Similar Businesses Nearby


                                        Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Competitive Landscape


                                        Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.                                        







Payments Accepted

NO DATA



Hours



                                        Sunday 

                                        

                                                                                            --
                                            
                                        



                                        Monday 

                                        

                                                                                            --
                                            
                                        



                                        Tuesday 

                                        

                                                                                            --
                                            
                                        



                                        Wednesday 

                                        

                                                                                            --
                                            
                                        



                                        Thursday 

                                        

                                                                                            --
                                            
                                        



                                        Friday 

                                        

                                                                                            --
                                            
                                        



                                        Saturday 

                                        

                                                                                            --
                                            
                                        







P

VIEW ADDITIONAL DATA                        
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it. 







Credibility Review





Google





Facebook.com





Yellowbook.com





Bing.com





Yellowpages.com





MerchantCircle





Tele Atlas (TomTom)





Twitter.com





AOL





MapQuest





Yahoo Local





Apple/Siri





Groupon





Hotfrog.com





Comcast.net Search





ReachLocal





Admedia





Dealsplus





Shoptopia.com





Alteryx





Dogtime Media





KSL.com





Sirtune





AmericanTowns.com





Driverside





Kudzu.com





SpecialsAgent.com





Answers.com





eGood





LawInfo.com





spotlikes.com





anywho.com





eGumball





Likeness.com





Spotzot





eServiceLog





MapMyRun





TechnoCom





apartmentguide.com





ezlocal.com





EZToUse.com





Teleroute





AroundMe.com





metropolist.com





Therapists.com





Atlanta NewHomes





FindLaw.com





Time Out New York





Avantar





FindTheBest.com





mojopages.com





B2B Yellowpages





Fivestar Software





MyCityWay.com





TripAdvisor





bckyrd.com





GiftCards.com





MyCoupons.com





beachcalifornia.com





GoLocal247.com





mymove.com





UpMeSocial.com





Belo





GoodInfo





News-Gazette





Nokia





usdirectory.com





Cars.com





Nomao





Centzy.com





hibu





Openlist.com





ChaCha Search





Homeplate.com





OwnLocal.com





VisiKard





challama.com





Homestore





patch.com





Voltari





CityBot





Pelopidas





Vouchd





ClassifiedAds





Hostway





PlaceIQ





WalkScore.com





CloudMade





Hoodoyou





PlanetDiscover.com





WeddingWire.com





PowerProfiles





Where Inc.





Contractors.com





iGoLocal.com





Radiate Media





Wikiocity





CouponMap





Indeed.com





Wimgo.com





CrowdSpot





Innova Electronics





Intellistrand





realtor.com





DataSphere





InTheMO.com





Reply.com





Yellowbot.com





JiWire





Rocket Fuel





YellowPageCity.com





DMV.org





Justclicklocal.com





Dirxion





Keen.com





Zidster.com












Photos














































Business Credit Report
Receive a one-time comprehensive credit report on this company.
get full credit report


Facebook








Twitter








Yelp






































Call 1.800.280.0780 to speak with a D&B Advisor Today!







Customer Resources
Products
Education Center
Business Articles & Insights
Glossary
Contact Us
Customer Support
Communication Preferences
Search for D&B D-U-N-S




Our Company
About Us
Company History
Business Credit History
Careers
Press Releases
News
Success Stories
Hoovers




Our Network
Partners
Affiliates
Blog
Access to Capital
Entrepreneurial Initiative
D&B International
SupplierEdge




Site Links
Business Directory
Site Map
PIPEDA
Privacy Policy
Website Terms of Service
Product License Agreement







© Dun & Bradstreet, Inc. 2017. All rights reserved.














 






Angus Edwardson, Product Director, GatherContent


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Angus Edwardson



Product Director
at
GatherContent


Location: Edinburgh, United Kingdom





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Angus Edwardson



Product Director
at
GatherContent


Location: Edinburgh, United Kingdom




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Angus Edwardson Product Director at GatherContent.
Leading the product. Defining, and refining, and re-refining, the thing that is, the product that is, the wonderful service called GatherContent. Also dabbling in poetry.



3

Companies in Career





N/A

Related Markets





3

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Specialized Design Services




Tags
User Experience, Interaction Design, Content Strategy




Topics of Influence












N/A







N/A






























Careers








Achievements








Investments








Related People






 Edit
View all 



Angus EdwardsonCareer (5)






Apr-2014




GatherContent



Product Director







Nov-2011 to Apr-2014




GatherContent



Product Manager







Sep-2010 to Sep-2011




Edinburgh Napier University



MDes Interaction Design Student







Mar-2010 to Sep-2011




Rowing Association of Maldives



Web Designer







Feb-2011 to Jun-2011




Edinburgh Napier University



Postgraduate Tutor - Digital Business Environments








Competencies










 Edit
View all 



Angus EdwardsonEducation (2)






2011



Edinburgh Napier University


Mdes, Interaction Design with Distinction, Awarded a Distinction






2009



Edinburgh Napier University


1st Class Bdes(Hons), Product Design, First Class Honours









 Edit



Angus EdwardsonAchievements and Recognitions





Add Milestone


No milestones has been recorded for Angus Edwardson






 Edit



Angus EdwardsonLinks





Add Link


No links has been recorded for Angus Edwardson









Angus EdwardsonInvestments/Acquisitions





No investments has been recorded for Angus Edwardson









Angus EdwardsonInvestments Representing Others





No investment reps has been recorded for Angus Edwardson








Angus EdwardsonRelated People








Colleagues at GatherContent







Peter Legierski

Lead Developer
Feb-2011









Alice Deer

Founder
Sep-2010









James Deer

Founder & Product Director
Sep-2010








View all 
Peers (5)







Griffin Dorman

Director of Product of Scripted









Hélène Brevet

Product Marketing Director of Scoop.it









Niraj Naik

Director, Product Management of Kapost









James Deer

Founder & Product Director of GatherContent









Bruce  Wilson

Director of Product Marketing of Trapit












View all 



Angus EdwardsonRecommended Market Profiles (2)








Content Marketing (ChiefMartec.com)

5,000 - 10,000 employees
92 companies








  Content Marketing: Additional Companies

1,000 - 2,500 employees
27 companies


















